Apertura Gene Therapy

Newyork, United Kingdom

Apertura Gene Therapy is a biotechnology company that treats debilitating diseases with limited options.

$67.0M raised

Apr 2022

Series A

Biotechnology Health Care Medical

Top Investors

Deerfield

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Apertura Gene Therapy

How much funding has Apertura Gene Therapy raised?

Apertura Gene Therapy has raised $67.0M in total funding. The most recent round was Series A. The last funding was announced in April 2022.

Who are Apertura Gene Therapy's investors?

Apertura Gene Therapy's investors include Deerfield.

Where is Apertura Gene Therapy headquartered?

Apertura Gene Therapy is headquartered in Newyork, United Kingdom.

What does Apertura Gene Therapy do?

Apertura Gene Therapy is a biotechnology company that treats debilitating diseases with limited options.

What stage is Apertura Gene Therapy at?

Apertura Gene Therapy is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 26, 2022.

MLA

"Apertura Gene Therapy — Funding & Investors." VCBacked, April 26, 2022, https://www.vcbacked.co/company/apertura-gene-therapy. Accessed July 2, 2026.

APA

VCBacked. (2022). Apertura Gene Therapy — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/apertura-gene-therapy

Wikipedia (cite web)

{{cite web |title=Apertura Gene Therapy — Funding & Investors |url=https://www.vcbacked.co/company/apertura-gene-therapy |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 26, 2022.